MIAMI, Jan. 23, 2021 /PRNewswire/ – eMedâ¢, a digital health company democratizing healthcare through digital point-of-care solutions, announced it will begin to administer the FDA-authorized, at-home symptomatic BinaxNOW⢠COVID-19 Ag Card rapid home test to 100,000 qualified individuals across the U.S. who order through eMed.com beginning today. These 100,000 individuals will be among the first to use eMed’s transformative approach to at-home testing. At $25 each, the eMed-administered rapid tests are the first virtually guided, at-home tests available and the most affordable testing option on the market with authenticated results automatically reported to public health authorities.”We are thrilled to share with …
